Certificate anatomy · C-023
How to read a peptide certificate of analysis
Read the fields before the headline result. Identify the sample, batch, method, specification, result, laboratory, dates and sign-off. Then decide whether each field is adequate, silent or inconsistent.
A peptide certificate of analysis should let you determine who tested which sample, for which batch, with which analytical procedure, against which criterion, on which date, and with what result. A percentage at the centre of the page is not enough. Read the certificate as a traceable record, then match it to the vial separately.
A COA can support only the tests shown for the described sample. It cannot establish an unstated attribute, prove the sample's origin, or transfer automatically to every vial sold under the same product name.
Annotated example
Find these fields on the document
The layout varies by laboratory. The information should still form a coherent chain from sample receipt to authorised result. Use the numbered specimen to locate the fields, then apply the questions alongside it.
- Sample identityDoes the sample name match the compound, form and description being claimed?
- Batch or lot referenceCan the identifier be matched exactly to the vial or packaging?
- Analytical methodIs the procedure named precisely enough to understand the measurand?
- Specification and resultAre the acceptance criterion, units and observed result kept distinct?
- Laboratory and datesCan you identify the issuer and place receipt, testing and issue dates in a coherent sequence?
- Authorised sign-offIs there a named or otherwise verifiable approval route?
Field-by-field decision
Classify what the certificate tells you
Use “adequate” only when the field answers the question clearly. “Silent” means the document does not say. “Check” means two fields conflict or a claim cannot be reconciled.
| Field | Adequate | Silent | Check for inconsistency |
|---|---|---|---|
| Sample identity | Exact compound and sample description | Generic “peptide” or no sample description | Name, form or code differs across sections |
| Batch reference | Unique and visible identifier | No batch or lot field | Certificate and vial show different references |
| Method | Named procedure linked to the reported attribute | “Lab tested” without a procedure | Method cannot reasonably support the headline claim |
| Specification | Criterion and units stated separately from result | No stated criterion | Pass label conflicts with the reported result |
| Result | Observed result, calculation basis and units are clear | Only a pass badge or marketing summary | Values conflict between summary and data |
| Laboratory | Issuer can be independently located and contacted | No legal name, address or verification route | Branding or contact details do not match the issuer |
| Date and approval | Coherent dates and attributable approval | Undated or unsigned document | Issue date, sample date or revision cannot be reconciled |
A pass means the stated criterion was met for the reported result and sample. It does not turn an unmeasured attribute into a pass, nor does it prove that the sample came from the vial you hold.
Practical sequence
Read a COA in five passes
- 01
Identify the issuer and sample
Record the laboratory's legal name, the sample description and the certificate reference. Do not begin with the largest percentage on the page.
OutputIssuer, sample and document ID.
- 02
Match the batch reference
Compare every character with the vial and packaging. Use the separate guide to match the certificate to your vial.
OutputMatched, unmatched or no reference.
- 03
Pair each method with one attribute
Name what the procedure measured. Read what each test actually measures before interpreting the result.
OutputMethod, measurand and limit.
- 04
Separate specification from result
The specification is the criterion. The result is the observation. Check the calculation basis and units before accepting a comparison.
OutputCriterion, result and stated outcome.
- 05
Verify and record gaps
Use the laboratory's independently found contact route. Check the red flags to look for and preserve a dated copy of the document.
OutputAdequate, silent or check.
Do not merge the claims
A purity figure answers a narrower question
Official basis
Why these fields appear in the checklist
WHO good manufacturing practice guidance for active pharmaceutical ingredients describes laboratory records that include the sample source, batch or lot reference, method, sample amount, reference standards, raw data, calculations, results, signatures, dates and review. This is a useful record-quality benchmark. It does not prove that a consumer-market certificate was produced under that system.
ICH Q2(R2) frames analytical procedure validation around fitness for an intended purpose. That principle prevents a method label from being treated as proof of a claim it was not designed to test.
- WHO GMP for active pharmaceutical ingredients · laboratory and batch record expectations.
- ICH Q2(R2) via FDA · analytical procedure validation and intended purpose.
Editorial rule: We describe missing fields as absent, not fraudulent. Authentication requires confirmation from the issuing laboratory or another reliable record. Sources checked 7 August 2026.
Editorial experience
From our work: how we checked this page
For topical-map item C-023, How to read a peptide certificate of analysis was checked as a distinct editorial task, not treated as a generic peptide page. We reviewed 2 unique external sources and 10 internal destinations in the page, then checked that the opening answer, headings, source descriptions and linked next steps stayed within the same claim boundary. The count records links in the published page and is not a claim that every source carries equal evidential weight.
Eleni Kiromitis checked the laboratory and scientific wording, drawing on direct experience commissioning laboratory tests and reviewing certificates of analysis and chromatograms. She checked whether each method was matched to the attribute it can measure, whether sample and batch limits remained visible, and whether the conclusion stopped where the analytical record stopped. Yianni Kiromitis retained responsibility for source verification, editorial decisions and correction management.
We did not use patient experience, a personal treatment outcome, seller testimony or an assumed product identity to support this page. The publication did not independently test a vial for this review. Where a page refers to a laboratory result, that result applies only to the named sample, method and attribute. We kept uncertainty beside the conclusion, recorded which source supports each material claim, and checked that the visible review date matches the publication record. A new controlled study, regulator update, corrected source, analytical report or credible safety signal can trigger reassessment through the public correction route.